- Accueil
- Chercheurs
- Mme Nathalie Châteauvert

Clinicien(ne) chercheur(-euse)
Mme Nathalie Châteauvert
Cardiologie
Publications
9- Boutin R, Leclerc V, Châteauvert N.. Conversion du PrografMD au Sandoz TacrolimusMD chez des patients ayant subi une greffe cardiaque.. Pharmactuel 2020; 53(1):34-39.
- Sénéchal I, Châteauvert N, Gervais P, Voisine P, Dubois M, Sénéchal M. Complex drug interactions in an HIV-seropositive heart transplant recipient.. Turk Kardiyol Dern Ars 2020; 48(2):180-184.
- Johnson Kuan WY, Châteauvert N, Leclerc V, Drolet B.. Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants.. Can J Hosp Pharm 2021; 74(4):317-326.
- Leclerc V, Sanctuaire A, Châteauvert N. Gestion de l'interaction entre le tacrolimus et le nirmatrelvir/ritonavir dans le traitement de la COVID-19 en transplantation d'organe solide.. Can J Hosp Pharm 2023; 76(3):254-256.
- Tymko MM, Drapeau A, Vieira-Coelho MA, Labrecque L, Imhoff S, Coombs GB, Langevin S, Fortin M, Châteauvert N, Ainslie PN, Brassard P. New evidence for baroreflex and respiratory chemoreflex mediated cerebral sympathetic activation in humans.. J Appl Physiol (1985) 2024; 0(0):Epub.
- Tymko MM, Drapeau A, Vieira-Coelho MA, Labrecque L, Imhoff S, Coombs GB, Langevin S, Fortin M, Châteauvert N, Ainslie PN, Brassard P. Acute isometric and dynamic exercise do not alter cerebral sympathetic nerve activity in healthy humans.. J Cereb Blood Flow Metab 2024; 44(10):1840-1851.
- Lellouche F, Blais-Lecours P, Maltais F, Sarrazin JF, Rola P, Nguyen T, Châteauvert N, Marsolais D. Ozanimod Therapy in Patients With COVID-19 Requiring Oxygen Support: A Randomized Open-Label Pilot Trial.. Chest 2024; 165(4):810-819.
- Domain G, Blais-Lecours P, Strubé C, Dognin N, Châteauvert N, Savard N, Nguyen T, Rola P, Marsolais D, Lellouche F, Sarrazin JF. Cardiac Safety of Ozanimod Use, a Novel Sphingosine-1-Phosphate Receptor Ligand, in COVID-19 Patients Requiring Oxygen: Secondary Analysis of the COZI Randomized Clinical Trial.. CJC Open 2024; 6(9):1035-1041.
- Tymko MM, Drapeau A, Vieira-Coelho MA, Labrecque L, Imhoff S, Coombs GB, Langevin S, Fortin M, Châteauvert N, Ainslie PN, Brassard P. New evidence for baroreflex and respiratory chemoreflex-mediated cerebral sympathetic activation in humans.. J Appl Physiol (1985) 2025; 138(2):366-377.